Cadrenal Therapeutics
CVKD
CVKD
9 hedge funds and large institutions have $752K invested in Cadrenal Therapeutics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and closing their positions.
Holders
9
Holders Change
+6
Holders Change %
+200%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $668K | 982,285 | +982,285 | New |
|
2
Geode Capital Management
Boston,
Massachusetts
| $26.4K | 38,745 | +38,745 | New |
|
3
Citadel Advisors
Miami,
Florida
| $19.8K | 29,114 | +29,114 | New |
|
|
VF
4
Virtu Financial
New York
| $17K | 25,472 | +25,472 | New |
|
|
BFO
5
Biltmore Family Office
Charlotte,
North Carolina
| $7.48K | 11,000 | +11,000 | New |
|
|
TSS
6
Two Sigma Securities
New York
| $7.37K | 10,830 | +10,830 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $5.76K | 8,475 | +8,205 | +3,039% |
|
8
UBS Group
Zurich,
Switzerland
| $92 | 135 | +131 | +3,275% |
|
9
Wells Fargo
San Francisco,
California
| $34 | 50 | +40 | +400% |
|
|
CFGS
10
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|